Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06513156 · ClinicalTrials.gov registry record · NA
Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications From Drug Use
A NA study of Opioid Use Disorder and Stimulant Use Disorder, sponsored by Elana Rosenthal.
- Recruiting
- Registry status
- NA
- Development phase
- 304
- Enrollment target
- 4
- Study locations
NCT06513156: Recruiting NA study of Opioid Use Disorder and Stimulant Use Disorder, sponsored by Elana Rosenthal.
NCT06513156 is a NA study of Opioid Use Disorder and Stimulant Use Disorder that is actively recruiting participants, run by Elana Rosenthal. The registered enrollment target is 304 participants, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (93% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06513156, a NA study of Opioid Use Disorder and Stimulant Use Disorder, is actively recruiting participants, sponsored by Elana Rosenthal.
- RECRUITING
- Registry status
- NA
- Development phase
- 304 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is a two-group randomized controlled trial conducted at five hospitals across the U.S. designed to test the effectiveness of an Integrated infectious diseases/Substance Use Disorder outpatient clinic (IC) compared to treatment as usual aimed at reducing infection related readmissions and improving health outcomes in people hospitalized with an infection related to injecting opioids or stimulants.
Primary Outcome
New hospitalization due to infection following discharge for index hospitalization
Conditions Studied
Interventions
- BEHAVIORAL Integrated Infectious Diseases and Substance Use Disorder Clinic (IC)
Study Locations (4)
District of Columbia
- George Washington University - Washington D.C.
Georgia
- Emory University - Atlanta
Maryland
- University of Maryland Baltimore - Baltimore
West Virginia
- West Virginia University - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2027-07-30 |
| Phase | NA |
What NCT06513156 shows while recruiting
NCT06513156 is an interventional study that assigns participants to a tested intervention. The registered 304 participants enrollment target is mid-sized for trials with a published cap, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (93% lower).
The record links to 3 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Integrated Infectious Diseases and Substance Use Disorder Clinic (IC) is the first listed.
NCT06513156 reports a single indexed study location in District of Columbia, Georgia, Maryland.
Frequently Asked Questions
What is clinical trial NCT06513156 about?
NCT06513156 is a clinical study titled "Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications From Drug Use". This is a two-group randomized controlled trial conducted at five hospitals across the U.S. designed to test the effectiveness of an Integrated infectious diseases/Substance Use Disorder outpatient clinic (IC) compared to treatment as usual aimed at reducing infection related readmissions and improv...
What is the current status of trial NCT06513156?
This trial is currently recruiting. It is a NA study. The enrollment target is 304 participants. The study started on 2024-10-01. Estimated completion is 2027-07-30.
What conditions does trial NCT06513156 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Stimulant Use Disorder, Injection Related Infections.
What interventions are being tested in trial NCT06513156?
The interventions under investigation include: Integrated Infectious Diseases and Substance Use Disorder Clinic (IC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06513156?
This trial is sponsored by Elana Rosenthal, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06513156 being conducted?
This trial has 4 study locations across District of Columbia, Georgia, Maryland, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06513156's enrollment target sits among peer trials
304 54th of 257 higher than 204 of 257 other Opioid Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04750616 · 304 participants · Phase 2
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
- NCT04994717 · 304 participants · Phase 3
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
- NCT06036147 · 304 participants · NA
Concussion Health Improvement Program
- NCT06096844 · 304 participants · Phase 3
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI